These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31289519)

  • 1. Incidence and significance of psammoma bodies in Xp11.2 translocation renal cell carcinoma and papillary renal cell carcinoma.
    Liu N; Qu F; Wei K; Gan W; Wang Z; Zhuang W; Agizamhan S; Ma W; Yang J; Chen M; Xu L; Guo H; Li D
    Oncol Lett; 2019 Jul; 18(1):472-478. PubMed ID: 31289519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast-Enhanced Ultrasound Features of Adult Xp11.2 Translocation Renal Cell Carcinoma: Differential Diagnosis With Three Main Renal Cell Carcinoma Subtypes.
    Ma W; Zhang F; Huang H; Wang W; Zhu Y; Lu Y; Guo H; Gan W
    J Ultrasound Med; 2022 Nov; 41(11):2673-2685. PubMed ID: 35103338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-enhanced ultrasound findings of adult renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion: comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma.
    Wei S; Tian F; Xia Q; Huang P; Zhang Y; Xia Z; Wu M; Yang B
    Cancer Imaging; 2019 Dec; 20(1):1. PubMed ID: 31892340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Differential diagnosis between renal cell carcinoma associated with XP11.2 translocation/TFE gene fusion and papillary renal cell carcinoma based on CT and MRI findings].
    Zhu Q; Zhu W; Wu J; Fu J; Chen W; Wang Z
    Zhonghua Yi Xue Za Zhi; 2014 May; 94(19):1470-2. PubMed ID: 25143166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative neutrophil-to-lymphocyte ratio predicts the surgical outcome of Xp11.2 translocation/TFE3 renal cell carcinoma patients.
    Agizamhan S; Qu F; Liu N; Sun J; Xu W; Zhang L; Guo H; Gan W
    BMC Urol; 2018 Jun; 18(1):60. PubMed ID: 29890986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene Expression Analysis of Aggressive Adult Xp11.2 Translocation Renal Cell Carcinoma at Clinical Stage T1N0M0 to Identify Potential Prognostic and Therapeutic Biomarkers.
    Park JS; Lee ME; Jang WS; Kim J; Park SM; Ham WS
    Biomedicines; 2022 Jan; 10(2):. PubMed ID: 35203530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic Contrast-Enhanced CT Characterization of Xp11.2 Translocation/TFE3 Gene Fusions versus Papillary Renal Cell Carcinomas.
    He J; Zhou K; Zhu B; Zhang G; Li X; Guo H; Gan W; Zhou Z; Liu T
    Biomed Res Int; 2015; 2015():298679. PubMed ID: 26636097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PRCC-TFE3 dual-fusion FISH assay: A new method for identifying PRCC-TFE3 renal cell carcinoma in paraffin-embedded tissue.
    Xiong L; Chen X; Liu N; Wang Z; Miao B; Gan W; Li D; Guo H
    PLoS One; 2017; 12(9):e0185337. PubMed ID: 28949976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Heterogeneity of Xp11.2 Translocation Renal Cell Carcinoma: The Correlation Between Split Signal Pattern in FISH and Prognosis.
    Zhu Y; Pu X; Dong X; Ji C; Guo H; Li D; Zhao X; Gan W
    Cancer Manag Res; 2021; 13():2419-2431. PubMed ID: 33758541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinicopathologic and molecular genetic study of renal cell carcinoma occurring in teenagers].
    Rao Q; Zhou J; Zhang RS; Ma HH; Zhou HB; Lu ZF; Zhou XJ
    Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):582-6. PubMed ID: 21092583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum.
    Rao Q; Williamson SR; Zhang S; Eble JN; Grignon DJ; Wang M; Zhou XJ; Huang W; Tan PH; Maclennan GT; Cheng L
    Am J Surg Pathol; 2013 Jun; 37(6):804-15. PubMed ID: 23598965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular-genetic analysis is essential for accurate classification of renal carcinoma resembling Xp11.2 translocation carcinoma.
    Hayes M; Peckova K; Martinek P; Hora M; Kalusova K; Straka L; Daum O; Kokoskova B; Rotterova P; Pivovarčikova K; Branzovsky J; Dubova M; Vesela P; Michal M; Hes O
    Virchows Arch; 2015 Mar; 466(3):313-22. PubMed ID: 25544614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic Characteristics and Prognosis of Xp11.2 Translocation Renal Cell Carcinoma: Multicenter, Propensity Score Matching Analysis.
    Choo MS; Jeong CW; Song C; Jeon HG; Seo SI; Hong SK; Byun SS; Chung JS; Hong SH; Hwang EC; Kim HH; Kwak C;
    Clin Genitourin Cancer; 2017 Oct; 15(5):e819-e825. PubMed ID: 28549862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnant patient with Xp11.2/transcription factor E3 translocation renal cell carcinoma: a case report and literature review.
    Wang Y; Guo X; Meng Z; Cui Y; Sun Y
    Front Oncol; 2024; 14():1388880. PubMed ID: 38988705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomorphologic comparison of type 1 and type 2 papillary renal cell carcinoma: A retrospective analysis of 28 cases.
    Magers MJ; Perrino CM; Cramer HM; Wu HH
    Cancer Cytopathol; 2019 Jun; 127(6):370-376. PubMed ID: 31091016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDCT findings of renal cell carcinoma associated with Xp11.2 translocation and TFE3 gene fusion and papillary renal cell carcinoma.
    Woo S; Kim SY; Lee MS; Moon KC; Kim SH; Cho JY; Kim SH
    AJR Am J Roentgenol; 2015 Mar; 204(3):542-9. PubMed ID: 25714283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xp11.2 translocation/TFE3 gene fusion renal cell carcinoma with a micropapillary pattern: cases report and literature review.
    Xu ZY; Wang JP; Zhang Y; Wu SW; Ma L; Qin YZ; Wang ZP; Chai DM; Tao YS
    Am J Transl Res; 2019; 11(1):327-339. PubMed ID: 30787990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA expression profiling of Xp11 renal cell carcinoma.
    Marchionni L; Hayashi M; Guida E; Ooki A; Munari E; Jabboure FJ; Dinalankara W; Raza A; Netto GJ; Hoque MO; Argani P
    Hum Pathol; 2017 Sep; 67():18-29. PubMed ID: 28411178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xp11 translocation renal cell carcinoma morphologically mimicking clear cell-papillary renal cell carcinoma in an adult patient: report of a case expanding the morphologic spectrum of Xp11 translocation renal cell carcinomas.
    Parihar A; Tickoo SK; Kumar S; Arora VK
    Int J Surg Pathol; 2015 May; 23(3):234-7. PubMed ID: 25519951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender difference analysis of Xp11.2 translocation renal cell carcinomas's attack rate: a meta-analysis and systematic review.
    Zhuang W; Liu N; Guo H; Zhang C; Gan W
    BMC Urol; 2020 Aug; 20(1):130. PubMed ID: 32843027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.